PURA VIDA INVESTMENTS, LLC - Q4 2019 holdings

Add to watchlist

$1.14 Billion is the total value of PURA VIDA INVESTMENTS, LLC's 100 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 102.2% .

All

			Value		Shares		↓ Weighting
SPY	New	SPDR S&P 500 ETF TRput	$156,488,000	–	486,200	+100.0%	13.77%	–
IWM	Buy	ISHARES TRput	$42,743,000	+125.9%	258,000	+106.4%	3.76%	+16.3%
XLV	Buy	SELECT SECTOR SPDR TRput	$41,050,000	+82.2%	403,000	+61.2%	3.61%	-6.2%
XBI	Buy	SPDR SER TRput	$40,707,000	+255.9%	428,000	+185.3%	3.58%	+83.3%
ABMD	New	ABIOMED INCput	$30,194,000	–	177,000	+100.0%	2.66%	–
MDT	New	MEDTRONIC PLCcall	$30,178,000	–	266,000	+100.0%	2.66%	–
IHI	New	ISHARES TRput	$28,811,000	–	109,000	+100.0%	2.54%	–
INSP	Buy	INSPIRE MED SYS INC	$28,470,000	+30.4%	383,640	+7.3%	2.50%	-32.8%
UNH	Buy	UNITEDHEALTH GROUP INCput	$27,634,000	+323.8%	94,000	+213.3%	2.43%	+118.2%
NSTG	Buy	NANOSTRING TECHNOLOGIES INC	$26,834,000	+42.2%	964,570	+10.4%	2.36%	-26.7%
VRAY	Buy	VIEWRAY INC	$26,809,000	+1158.0%	6,352,939	+764.4%	2.36%	+547.8%
FXH	Buy	FIRST TR EXCHANGE TRADED FDput	$22,650,000	+22.4%	269,000	+7.6%	1.99%	-37.0%
QGEN	New	QIAGEN NVcall	$20,043,000	–	593,000	+100.0%	1.76%	–
ZBH	Buy	ZIMMER BIOMET HLDGS INC	$19,577,000	+21.4%	130,790	+11.4%	1.72%	-37.5%
ICUI	Buy	ICU MED INC	$19,333,000	+31.0%	103,320	+11.7%	1.70%	-32.6%
STAA	Buy	STAAR SURGICAL CO	$18,996,000	+46.2%	540,110	+7.2%	1.67%	-24.7%
ESTA	Sell	ESTABLISHMENT LABS HLDGS INC	$18,881,000	+34.0%	682,600	-8.4%	1.66%	-31.0%
NSTG	Sell	NANOSTRING TECHNOLOGIES INCcall	$18,194,000	+18.7%	654,000	-7.9%	1.60%	-38.9%
XENT	Buy	INTERSECT ENT INC	$18,186,000	+59.6%	730,360	+9.0%	1.60%	-17.8%
BHVN	Buy	BIOHAVEN PHARMACTL HLDG CO Lcall	$17,802,000	+42.2%	327,000	+9.0%	1.57%	-26.8%
ILMN	Buy	ILLUMINA INCcall	$17,250,000	+89.0%	52,000	+73.3%	1.52%	-2.7%
BAX	New	BAXTER INTL INCcall	$17,184,000	–	205,500	+100.0%	1.51%	–
XENT	Sell	INTERSECT ENT INCcall	$16,285,000	+23.5%	654,000	-15.6%	1.43%	-36.4%
SRPT	Buy	SAREPTA THERAPEUTICS INCput	$14,065,000	+86.7%	109,000	+9.0%	1.24%	-3.9%
AMRN	New	AMARIN CORP PLCput	$14,022,000	–	654,000	+100.0%	1.23%	–
GRFS	Buy	GRIFOLS S Asp adr rep b nvt	$13,476,000	+35.5%	578,620	+16.6%	1.18%	-30.3%
INOV	Buy	INOVALON HLDGS INC	$13,333,000	+984.9%	708,470	+844.6%	1.17%	+458.6%
AGN	Buy	ALLERGAN PLC	$13,334,000	+18.1%	69,750	+3.9%	1.17%	-39.2%
ICUI	Buy	ICU MED INCcall	$13,286,000	+202.7%	71,000	+158.2%	1.17%	+55.9%
OCX	New	ONCOCYTE CORP	$12,817,000	–	5,696,576	+100.0%	1.13%	–
INSP	Sell	INSPIRE MED SYS INCcall	$12,096,000	-27.9%	163,000	-40.7%	1.06%	-62.9%
IVC	Buy	INVACARE CORP	$12,073,000	+96.3%	1,338,493	+63.3%	1.06%	+1.1%
DXCM	Buy	DEXCOM INC	$12,049,000	+79.4%	55,082	+22.4%	1.06%	-7.6%
ABT	New	ABBOTT LABSput	$11,900,000	–	137,000	+100.0%	1.05%	–
STAA	New	STAAR SURGICAL COput	$11,501,000	–	327,000	+100.0%	1.01%	–
KIDS	Buy	ORTHOPEDIATRICS CORP	$11,437,000	+88.0%	243,392	+41.1%	1.01%	-3.2%
QGEN	New	QIAGEN NVput	$11,053,000	–	327,000	+100.0%	0.97%	–
NVRO	New	NEVRO CORPcall	$10,814,000	–	92,000	+100.0%	0.95%	–
CSII	New	CARDIOVASCULAR SYS INC DELput	$10,593,000	–	218,000	+100.0%	0.93%	–
RCM	Buy	R1 RCM INC	$10,509,000	+55.4%	809,610	+6.9%	0.92%	-20.0%
QTNT	Buy	QUOTIENT LTD	$10,370,000	+136.2%	1,090,400	+93.0%	0.91%	+21.6%
ZBH	Sell	ZIMMER BIOMET HLDGS INCcall	$9,879,000	-28.0%	66,000	-34.0%	0.87%	-62.9%
ALXN	Buy	ALEXION PHARMACEUTICALS INC	$9,430,000	+83.4%	87,190	+66.1%	0.83%	-5.5%
PKI	New	PERKINELMER INCput	$9,127,000	–	94,000	+100.0%	0.80%	–
DVA	New	DAVITA INCput	$8,403,000	–	112,000	+100.0%	0.74%	–
BCRX	New	BIOCRYST PHARMACEUTICALS INC	$7,521,000	–	2,179,950	+100.0%	0.66%	–
GKOS	New	GLAUKOS CORPput	$7,190,000	–	132,000	+100.0%	0.63%	–
SDC	New	SMILEDIRECTCLUB INCput	$7,167,000	–	820,000	+100.0%	0.63%	–
TXG	Sell	10X GENOMICS INC	$6,660,000	+46.8%	87,340	-3.0%	0.59%	-24.4%
OMCL	New	OMNICELL COMput	$6,456,000	–	79,000	+100.0%	0.57%	–
CGC	Buy	CANOPY GROWTH CORPput	$6,327,000	+0.3%	300,000	+9.1%	0.56%	-48.3%
AUPH	New	AURINIA PHARMACEUTICALS INC	$5,410,000	–	267,050	+100.0%	0.48%	–
CNMD	Sell	CONMED CORP	$5,181,000	+13.4%	46,330	-2.5%	0.46%	-41.5%
GH	New	GUARDANT HEALTH INCcall	$5,157,000	–	66,000	+100.0%	0.45%	–
MJ	New	ETF MANAGERS TRcall	$5,136,000	–	300,000	+100.0%	0.45%	–
APYX	Buy	APYX MEDICAL CORPORATION	$4,854,000	+68.4%	573,782	+34.7%	0.43%	-13.2%
GH	New	GUARDANT HEALTH INC	$4,685,000	–	59,960	+100.0%	0.41%	–
EXAS	New	EXACT SCIENCES CORPput	$4,624,000	–	50,000	+100.0%	0.41%	–
IMMU	New	IMMUNOMEDICS INCput	$4,613,000	–	218,000	+100.0%	0.41%	–
AXNX	New	AXONICS MODULATION TECHNOLOG	$4,530,000	–	163,490	+100.0%	0.40%	–
CI	New	CIGNA CORP NEWput	$4,499,000	–	22,000	+100.0%	0.40%	–
SRACU	New	STABLE RD ACQUISITION CORPunit 05/15/2026	$4,485,000	–	435,850	+100.0%	0.40%	–
MMSI	New	MERIT MED SYS INCcall	$4,433,000	–	142,000	+100.0%	0.39%	–
OTIC	Buy	OTONOMY INC	$4,367,000	+84.0%	1,140,163	+14.8%	0.38%	-5.4%
QGEN	New	QIAGEN NV	$4,218,000	–	124,780	+100.0%	0.37%	–
BYND	Buy	BEYOND MEAT INCput	$4,082,000	+56.9%	54,000	+208.6%	0.36%	-19.1%
IMVTU	New	IMMUNOVANT INCunit 12/18/2024	$4,047,000	–	165,170	+100.0%	0.36%	–
HZNP	New	HORIZON THERAPEUTICS PUB Lcall	$3,946,000	–	109,000	+100.0%	0.35%	–
MASI	Buy	MASIMO CORP	$3,858,000	+29.0%	24,409	+21.4%	0.34%	-33.7%
FLDM	Buy	FLUIDIGM CORP DEL	$3,796,000	+64.0%	1,090,830	+118.2%	0.33%	-15.4%
HCA	New	HCA HEALTHCARE INCput	$3,252,000	–	22,000	+100.0%	0.29%	–
MNTA	New	MOMENTA PHARMACEUTICALS INC	$3,226,000	–	163,490	+100.0%	0.28%	–
TGTX	Sell	TG THERAPEUTICS INC	$3,082,000	+54.7%	277,639	-21.7%	0.27%	-20.3%
IOVA	New	IOVANCE BIOTHERAPEUTICS INCcall	$3,017,000	–	109,000	+100.0%	0.26%	–
NTRA	Buy	NATERA INC	$2,571,000	+161.3%	76,300	+154.3%	0.23%	+34.5%
RCKT	New	ROCKET PHARMACEUTICALS INC	$2,481,000	–	109,000	+100.0%	0.22%	–
EOLS	New	EVOLUS INC	$2,380,000	–	195,583	+100.0%	0.21%	–
CABA	New	CABALETTA BIO INC	$2,162,000	–	154,792	+100.0%	0.19%	–
RCM	Sell	R1 RCM INCcall	$2,116,000	-32.3%	163,000	-53.4%	0.19%	-65.2%
ARDX	Buy	ARDELYX INC	$2,046,000	+210.9%	272,605	+94.6%	0.18%	+60.7%
INOV	Sell	INOVALON HLDGS INCcall	$2,051,000	-58.3%	109,000	-63.7%	0.18%	-78.6%
KALA	Buy	KALA PHARMACEUTICALS INC	$1,968,000	+55.5%	533,287	+60.2%	0.17%	-19.9%
NTRA	New	NATERA INCcall	$1,819,000	–	54,000	+100.0%	0.16%	–
GNLN	Sell	GREENLANE HLDGS INCcl a	$1,787,000	-56.7%	549,017	-54.9%	0.16%	-77.7%
DERM	New	DERMIRA INC	$1,673,000	–	110,350	+100.0%	0.15%	–
ADPT	New	ADAPTIVE BIOTECHNOLOGIES COR	$1,616,000	–	54,010	+100.0%	0.14%	–
NLTX	New	NEOLEUKIN THERAPEUTICS INC	$1,579,000	–	128,180	+100.0%	0.14%	–
NVAX		NOVAVAX INCcall	$1,305,000	-20.7%	327,800	0.0%	0.12%	-59.1%
STXS	New	STEREOTAXIS INC	$1,291,000	–	244,103	+100.0%	0.11%	–
SVRA	New	SAVARA INC	$1,286,000	–	287,110	+100.0%	0.11%	–
QURE	Buy	UNIQURE NV	$1,172,000	+98.6%	16,350	+9.0%	0.10%	+2.0%
ALKS	New	ALKERMES PLC	$1,102,000	–	54,000	+100.0%	0.10%	–
AVDL	Sell	AVADEL PHARMACEUTICALS PLCsponsored adr	$823,000	+63.0%	109,000	-10.2%	0.07%	-16.3%
ABEO	New	ABEONA THERAPEUTICS INC	$802,000	–	245,250	+100.0%	0.07%	–
SPPI	New	SPECTRUM PHARMACEUTICALS INCcall	$794,000	–	218,000	+100.0%	0.07%	–
AMRN	New	AMARIN CORP PLCspons adr new	$740,000	–	34,501	+100.0%	0.06%	–
CBAY	Buy	CYMABAY THERAPEUTICS INCcall	$641,000	-58.3%	327,000	+9.0%	0.06%	-78.6%
APLT	New	APPLIED THERAPEUTICS INC	$595,000	–	21,810	+100.0%	0.05%	–
HEXO	New	HEXO CORPput	$239,000	–	150,000	+100.0%	0.02%	–
SSPKW	New	SILVER SPIKE ACQUISITION COR*w exp 08/02/202	$20,000	–	50,000	+100.0%	0.00%	–
ALRN	Exit	AILERON THERAPEUTICS INC	$0	–	-135,548	-100.0%	-0.02%	–
ADVM	Exit	ADVERUM BIOTECHNOLOGIES INC	$0	–	-100,000	-100.0%	-0.09%	–
ENDP	Exit	ENDO INTL PLCcall	$0	–	-200,000	-100.0%	-0.11%	–
ITCI	Exit	INTRA CELLULAR THERAPIES INC	$0	–	-109,130	-100.0%	-0.14%	–
CHRS	Exit	COHERUS BIOSCIENCES INC	$0	–	-50,000	-100.0%	-0.17%	–
AXSM	Exit	AXSOME THERAPEUTICS INC	$0	–	-58,519	-100.0%	-0.20%	–
ZYME	Exit	ZYMEWORKS INC	$0	–	-50,000	-100.0%	-0.21%	–
STML	Exit	STEMLINE THERAPEUTICS INC	$0	–	-132,422	-100.0%	-0.24%	–
ARVN	Exit	ARVINAS INC	$0	–	-64,209	-100.0%	-0.24%	–
FLDM	Exit	FLUIDIGM CORP DELcall	$0	–	-300,000	-100.0%	-0.24%	–
DCPH	Exit	DECIPHERA PHARMACEUTICALS IN	$0	–	-41,000	-100.0%	-0.24%	–
SAGE	Exit	SAGE THERAPEUTICS INCcall	$0	–	-10,000	-100.0%	-0.24%	–
BHVN	Exit	BIOHAVEN PHARMACTL HLDG CO L	$0	–	-40,000	-100.0%	-0.28%	–
CMD	Exit	CANTEL MED CORPput	$0	–	-25,000	-100.0%	-0.32%	–
MSON	Exit	MISONIX INC	$0	–	-93,645	-100.0%	-0.32%	–
ACHN	Exit	ACHILLION PHARMACEUTICALS IN	$0	–	-566,600	-100.0%	-0.35%	–
CYTK	Exit	CYTOKINETICS INC	$0	–	-188,096	-100.0%	-0.37%	–
BDSI	Exit	BIODELIVERY SCIENCES INTL IN	$0	–	-515,111	-100.0%	-0.37%	–
TNDM	Exit	TANDEM DIABETES CARE INC	$0	–	-40,000	-100.0%	-0.40%	–
CSTL	Exit	CASTLE BIOSCIENCES INC	$0	–	-131,718	-100.0%	-0.41%	–
SUPN	Exit	SUPERNUS PHARMACEUTICALS INCput	$0	–	-100,000	-100.0%	-0.47%	–
IVC	Exit	INVACARE CORPcall	$0	–	-400,000	-100.0%	-0.51%	–
WMGI	Exit	WRIGHT MED GROUP N Vcall	$0	–	-150,000	-100.0%	-0.53%	–
UTHR	Exit	UNITED THERAPEUTICS CORP DEL	$0	–	-39,000	-100.0%	-0.53%	–
GWPH	Exit	GW PHARMACEUTICALS PLCads	$0	–	-30,000	-100.0%	-0.59%	–
MRTX	Exit	MIRATI THERAPEUTICS INCcall	$0	–	-50,000	-100.0%	-0.67%	–
SPPI	Exit	SPECTRUM PHARMACEUTICALS INCput	$0	–	-500,000	-100.0%	-0.71%	–
MDCO	Exit	MEDICINES COcall	$0	–	-100,000	-100.0%	-0.85%	–
BAX	Exit	BAXTER INTL INC	$0	–	-60,000	-100.0%	-0.90%	–
STAA	Exit	STAAR SURGICAL COcall	$0	–	-231,200	-100.0%	-1.02%	–
VRAY	Exit	VIEWRAY INCcall	$0	–	-2,250,000	-100.0%	-1.12%	–
CHRS	Exit	COHERUS BIOSCIENCES INCcall	$0	–	-400,000	-100.0%	-1.38%	–
SNN	Exit	SMITH & NEPHEW GROUP PLCspdn adr new	$0	–	-180,000	-100.0%	-1.48%	–
GILD	Exit	GILEAD SCIENCES INC	$0	–	-150,000	-100.0%	-1.62%	–
IBB	Exit	ISHARES TRcall	$0	–	-109,200	-100.0%	-1.86%	–
REGN	Exit	REGENERON PHARMACEUTICALS	$0	–	-40,000	-100.0%	-1.90%	–
WAT	Exit	WATERS CORPcall	$0	–	-50,000	-100.0%	-1.91%	–
SNN	Exit	SMITH & NEPHEW GROUP PLCcall	$0	–	-265,000	-100.0%	-2.18%	–
REGN	Exit	REGENERON PHARMACEUTICALScall	$0	–	-50,000	-100.0%	-2.37%	–
MJ	Exit	ETF MANAGERS TRput	$0	–	-700,000	-100.0%	-2.48%	–
AMGN	Exit	AMGEN INCcall	$0	–	-100,000	-100.0%	-3.31%	–

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR/A filed 2021-02-12

Signatures

The EDGAR filing(s) were signed by:

Alyssa Romano — Chief Compliance Officer and Chief Financial Officer

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
ICU MED INC	26	Q2 2023	4.2%
NANOSTRING TECHNOLOGIES INC	26	Q2 2023	3.3%
VIEWRAY INC	25	Q2 2023	3.2%
LIVANOVA PLC	23	Q3 2023	3.8%
ALEXION PHARMACEUTICALS INC	23	Q1 2021	4.3%
INSPIRE MED SYS INC	22	Q3 2023	3.7%
BOSTON SCIENTIFIC CORP	22	Q3 2022	4.8%
INVACARE CORP	22	Q3 2021	2.8%
ESTABLISHMENT LABS HLDGS INC	21	Q3 2023	5.0%
INTERSECT ENT INC	21	Q2 2021	2.6%

View PURA VIDA INVESTMENTS, LLC's complete holdings history.

Latest significant ownerships (13-D/G)

PURA VIDA INVESTMENTS, LLC Q4 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
Stryve Foods Holdings, LLC	April 19, 2023	1,470,649	5.6%
ICAD INC	March 15, 2023	1,277,214	5.0%
ESTABLISHMENT LABS HOLDINGS INC.	February 14, 2023	1,002,767	4.1%
Pulmonx Corp	February 14, 2023	1,216,258	3.2%
Quotient Ltd^{Sold out}	February 14, 2023	0	0.0%
Universe Pharmaceuticals INC^{Sold out}	February 14, 2023	0	0.0%
MedMen Enterprises, Inc.	April 29, 2022	139,755,072	21.4%
INVACARE CORP^{Sold out}	February 14, 2022	0	0.0%
MedAvail Holdings, Inc.	February 14, 2022	714,120	2.2%
TELA Bio, Inc.	February 14, 2022	564,120	3.9%

View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.

Latest filings

Type	Filed
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
13F-HR	2024-02-13
SC 13D/A	2023-12-29

View PURA VIDA INVESTMENTS, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

The reported total value is incorrect (1136740000.0 != 1136744000.0)
The reported has been restated
The reported has been amended

Export PURA VIDA INVESTMENTS, LLC's holdings